Wall Street Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.65M Buy
2,213
+37
+2% +$37.8K 1.42% 22
2026
Q1
$2M Sell
2,176
-52
-2% -$52.7K 1.19% 20
2025
Q4
$2.39M Buy
2,228
+100
+5% +$95.6K 1.74% 17
2025
Q3
$1.62M Buy
2,128
+73
+4% +$54.3K 1.19% 22
2025
Q2
$1.6M Buy
2,055
+297
+17% +$231K 1.45% 20
2025
Q1
$1.45M Sell
1,758
-1,029
-37% -$856K 1.5% 15
2024
Q4
$2.15M Sell
2,787
-2,766
-50% -$2.29M 2.1% 12
2024
Q3
$4.92M Buy
5,553
+42
+0.8% +$37.8K 5.19% 8
2024
Q2
$4.99M Buy
+5,511
New +$4.41M 8.48% 3

Other funds holding LLY

Wall Street Financial Group's LLY Position: Q2 2026 in Review

Wall Street Financial Group increased its Eli Lilly (LLY) stake by 1.7% in Q2 2026, buying an estimated $37.8K and bringing the position to 2,213 shares worth $2.65M. The position accounts for 1.42% of the portfolio, ranked #22.

Wall Street Financial Group first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.99M in Q2 2024. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Wall Street Financial Group held 2,213 shares of Eli Lilly worth $2.65M as of Q2 2026.
  • Wall Street Financial Group bought 37 Eli Lilly shares in Q2 2026, an estimated $37.8K.
  • Eli Lilly made up 1.42% of Wall Street Financial Group's portfolio in Q2 2026, its #22 holding.
  • Wall Street Financial Group first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • Wall Street Financial Group's Eli Lilly position peaked at $4.99M in Q2 2024.
  • 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wall Street Financial Group's 13F filing for Q2 2026, filed 14 Jul 2026.